Allarity Therapeutics, Inc. (ALLR) stock
ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.88−0.08 (-8.24%)
Close on Nov 16, 2026Market cap $13.93MP/E –Yield –
Allarity Therapeutics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Allarity Therapeutics's ebitda for the twelve months ending Jun 30, 2025 was -$26.77M. For fiscal 2024 it was -$27.23M. The highest annual figure on record is -$8.27M in fiscal 2020.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$27.23M | – |
| FY2023 | Dec 31, 2023 | -$17.09M | – |
| FY2022 | Dec 31, 2022 | -$34.40M | – |
| FY2021 | Dec 31, 2021 | -$26.45M | – |
| FY2020 | Dec 31, 2020 | -$8.27M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2025 | Jun 30, 2025 | -$4.12M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.03M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.32M | – |
| Q3 FY2024 | Sep 30, 2024 | -$12.31M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.37M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.24M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.87M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.42M | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.75M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.55M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.82M | – |
| Q1 FY2022 | Mar 31, 2022 | -$18.29M | – |
| Q4 FY2021 | Dec 31, 2021 | -$15.73M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.94M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.38M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.41M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.59M | – |
See a number that looks wrong?